CD137 Signaling Is Critical in Fungal Clearance during Systemic Candida albicans Infection

Vuvi G Tran1, Na N Z Nguyen1, Byungsuk Kwon1

  • 1School of Biological Science, University of Ulsan, Ulsan 44610, Korea.

Insights

Neutrophil CD137 signaling is crucial for fighting invasive Candida albicans infections. Activating CD137 enhances neutrophil antifungal activity, improving fungal clearance in immunocompromised patients.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Microbiology

Background:

  • Invasive fungal infections, particularly by Candida albicans, pose a significant threat to immunocompromised individuals.
  • Neutrophils are key players in clearing systemic C. albicans infections, but the specific surface receptors governing their antifungal functions remain largely unknown.
  • CD137 (Tnfrsf9) is a tumor necrosis receptor superfamily member known to modulate neutrophil responses in bacterial infections.

Purpose of the Study:

  • To investigate the role of neutrophil CD137 signaling in the innate immune defense against systemic Candida albicans infection.
  • To determine if CD137 activation enhances neutrophil phagocytic and fungicidal capabilities against C. albicans.

Main Methods:

  • Utilized genetic approaches, including Tnfrsf9 knockout (Tnfrsf9-/-) mice.
  • Employed immunological tools such as anti-CD137 agonistic antibodies.
  • Assessed neutrophil phagocytosis and fungicidal activity in vitro and fungal clearance in vivo.

Main Results:

  • Tnfrsf9-/- mice exhibited increased susceptibility to C. albicans infection.
  • Administration of anti-CD137 agonistic antibody conferred protection against systemic C. albicans infection.
  • Priming neutrophils with anti-CD137 antibody enhanced their phagocytic and fungicidal activities via phospholipase C.
  • Anti-CD137 antibody treatment improved fungal growth restriction in Tnfrsf9-/- mice reconstituted with wild-type neutrophils.

Conclusions:

  • CD137 signaling is essential for effective innate immunity against systemic Candida albicans infections.
  • CD137 activation by specific antibodies boosts neutrophil-mediated antifungal defense mechanisms.
  • Targeting CD137 signaling represents a potential therapeutic strategy to enhance fungal clearance in immunocompromised patients.